Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Financing › Details

Calliditas Therapeutics–SEVERAL: investment, 202005–202007 US IPO $81m+$6.9m with w 8.3m+707k common shares as ADSs at Nasdaq Global Market

 

Period Period 2020-05-14 ï¿½ 2020-07-02
Region Region United States (USA)
Organisations Money taker Calliditas Therapeutics AB (Nasdaq Stockholm: CALTX)
  Group Calliditas Therapeutics (Group)
  Money source SEVERAL
Products Product Nefecon®
  Product 2 investment banking
Index term Index term Calliditas Therapeutics–SEVERAL: investment, 202005–202006 private placement SEK82.9m with 924k common shares at SEK89.7/share outside US
Document Source Calliditas Therapeutics AB. (7/2/20). "Press Release: Exercise of Over-allotment Option and End of the Stabilization Period".
     

   
Record changed: 2021-01-14

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Calliditas Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner Network in German Capital Region 650x80px




» top